Month: April 2019

Louisville residents may be familiar with mesothelioma, a cancer caused usually by exposure to asbestos. The most common type is pleural mesothelioma, which affects the lining of the lungs. This type can be divided into three subtypes. Normally, chemotherapy is used...

Louisville residents may want to know about a new form of immunotherapy that has been shown to be effective in treating malignant pleural mesothelioma. CAR T-cell therapy involves a laboratory reprogramming of a patient's T cells, a certain type of white blood cell,...

Mesothelioma is difficult for doctors to diagnose in its early stages. Therefore, patients in Kentucky and elsewhere may have a harder time getting the care that they need to overcome the condition. However, medical professionals are using machine learning that may be...

Patients who suffer from mesothelioma in Louisville and across the country may soon have access to a promising new treatment. Every year, approximately 3,000 people in the United States are diagnosed with mesothelioma. When found early, mesothelioma has a 41 percent...

Mesothelioma patients in Louisville may have access to improved treatment in the years ahead based on research into a blood-clotting pathway. Researchers at the Langone Medical Center in New York and the Cancer and Vascular Biology Research Center in Haifa, Israel,...